Citation Impact
Citing Papers
clusterProfiler: an R Package for Comparing Biological Themes Among Gene Clusters
2012 Standout
Lymphocytic Reaction to Colorectal Cancer Is Associated with Longer Survival, Independent of Lymph Node Count, Microsatellite Instability, and CpG Island Methylator Phenotype
2009
The Humoral Immune System Has a Key Prognostic Impact in Node-Negative Breast Cancer
2008
Commensal Bifidobacterium promotes antitumor immunity and facilitates anti–PD-L1 efficacy
2015 StandoutScience
Clinical Impact of Different Classes of Infiltrating T Cytotoxic and Helper Cells (Th1, Th2, Treg, Th17) in Patients with Colorectal Cancer
2011
Programmed cell death 1 ligand 1 and tumor-infiltrating CD8 + T lymphocytes are prognostic factors of human ovarian cancer
2007 StandoutNobel
Prognostic Value of Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancers From Two Phase III Randomized Adjuvant Breast Cancer Trials: ECOG 2197 and ECOG 1199
2014
Prognostic and Predictive Value of Tumor-Infiltrating Lymphocytes in a Phase III Randomized Adjuvant Breast Cancer Trial in Node-Positive Breast Cancer Comparing the Addition of Docetaxel to Doxorubicin With Doxorubicin-Based Chemotherapy: BIG 02-98
2013
CD8+ lymphocyte infiltration is an independent favorable prognostic indicator in basal-like breast cancer
2012
Hallmarks of Cancer: The Next Generation
2011 Standout
Correlation between p53, c-erbB-2, and topoisomerase II? expression, DNA ploidy, hormonal receptor status and proliferation in 356 node-negative breast carcinomas: prognostic implications
1999
Prognostic significance of tumor-infiltrating T-lymphocytes in primary and metastatic lesions of advanced stage ovarian cancer
2008
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
2021 Standout
Gene expression profiling predicts clinical outcome of breast cancer
2002 StandoutNature
Cancer immunoediting: from immunosurveillance to tumor escape
2002 Standout
The anti-apoptosis function of Bcl-2 can be genetically separated from its inhibitory effect on cell cycle entry
1997
Ki67 LABELLING INDEX: AN INDEPENDENT PREDICTOR OF PROGRESSION IN PROSTATE CANCER TREATED BY RADICAL PROSTATECTOMY
1996
Tumor infiltrating Foxp3+ regulatory T‐cells are associated with recurrence in pathologic stage I NSCLC patients
2006
Prognostic value of hyaluronan expression in non-small-cell lung cancer: Increased stromal expression indicates unfavorable outcome in patients with adenocarcinoma
2001
Biologic Characteristics of Interval and Screen-Detected Breast Cancers
2000
Expression of tumor markers hyaluronic acid and hyaluronidase (HYAL1) in head and neck tumors
2003
Microsatellite Instability and High Content of Activated Cytotoxic Lymphocytes Identify Colon Cancer Patients with a Favorable Prognosis
2001
Bone marrow cells regenerate infarcted myocardium
2001 StandoutNature
Intratumoral T Cells, Recurrence, and Survival in Epithelial Ovarian Cancer
2003 Standout
The cancer glycocalyx mechanically primes integrin-mediated growth and survival
2014 StandoutNatureNobel
Leukocyte infiltration and tumor cell plasticity are parameters of aggressiveness in primary cutaneous melanoma
2007
The prognostic impact of M‐CSF, CSF‐1 receptor, CD68 and CD3 in prostatic carcinoma
2008
Hyaluronan-Cell Interactions in Cancer and Vascular Disease
2002
Imaging in the era of molecular oncology
2008 StandoutNature
Immunology and immunotherapy approaches for prostate cancer
2007
Hyaluronan: from extracellular glue to pericellular cue
2004 Standout
Role of HIF-1α in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis
1998 StandoutNatureNobel
Renal-Cell Carcinoma
1996 Standout
Tumor infiltrating lymphocytes are prognostic in triple negative breast cancer and predictive for trastuzumab benefit in early breast cancer: results from the FinHER trial
2014
Proliferation, cell cycle and apoptosis in cancer
2001 StandoutNature
Influence of tumour micro-environment heterogeneity on therapeutic response
2013 StandoutNature
CD3+ cells at the invasive margin of deeply invading (pT3–T4) colorectal cancer and risk of post-surgical metastasis: a longitudinal study
2009
Prostate-specific deletion of the murine Pten tumor suppressor gene leads to metastatic prostate cancer
2003 Standout
Differential oestrogen receptor binding is associated with clinical outcome in breast cancer
2012 StandoutNature
Immunology and immunotherapy of colorectal cancer
2003
The biochemistry of apoptosis
2000 StandoutNature
Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas
2007 StandoutNature
Stromal and Epithelial Expression of Tumor Markers Hyaluronic Acid and HYAL1 Hyaluronidase in Prostate Cancer
2001
Control of apoptosis and mitotic spindle checkpoint by survivin
1998 StandoutNature
FOXP3 and survival in urinary bladder cancer
2011
p21 in cancer: intricate networks and multiple activities
2009 Standout
The impact of T‐cell immunity on ovarian cancer outcomes
2008
Immune infiltration in human tumors: a prognostic factor that should not be ignored
2009
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
2016 Standout
Tumor-infiltrating lymphocytes: apparently good for melanoma patients. But why?
2011
CD8+ lymphocytes/ tumour-budding index: an independent prognostic factor representing a ‘pro-/anti-tumour’ approach to tumour host interaction in colorectal cancer
2009
Immunity, Inflammation, and Cancer
2010 Standout
CD8+ Tumor-Infiltrating Lymphocytes Together with CD4+ Tumor-Infiltrating Lymphocytes and Dendritic Cells Improve the Prognosis of Patients with Pancreatic Adenocarcinoma
2003
Molecular genetics of prostate cancer
2000
Perturbation of Hyaluronan Interactions by Soluble CD44 Inhibits Growth of Murine Mammary Carcinoma Cells in Ascites
2000
Hyaluronan in Peritumoral Stroma and Malignant Cells Associates with Breast Cancer Spreading and Predicts Survival
2000
Immunosurveillance of pancreatic adenocarcinoma: Insights from genetically engineered mouse models of cancer
2008
Cancer immunotherapy comes of age
2011 StandoutNature
Oncogenic functions of tumour suppressor p21Waf1/Cip1/Sdi1: association with cell senescence and tumour-promoting activities of stromal fibroblasts
2002
The immune contexture in human tumours: impact on clinical outcome
2012 Standout
Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis
2005 StandoutNature
Checkpoint Blockade in Cancer Immunotherapy
2006 StandoutNobel
Somatic cell type specific gene transfer reveals a tumor-promoting function for p21Waf1/Cip1
2007
The Ki-67 protein: From the known and the unknown
2000 Standout
Melanoma-intrinsic β-catenin signalling prevents anti-tumour immunity
2015 StandoutNature
The role of senescent cells in ageing
2014 StandoutNature
Intratumoral CD8+ T/FOXP3+ cell ratio is a predictive marker for survival in patients with colorectal cancer
2009
Cancer exome analysis reveals a T-cell-dependent mechanism of cancer immunoediting
2012 StandoutNatureNobel
The Hallmarks of Aging
2013 Standout
Escaping Cell Death: Survival Proteins in Cancer
1999
Apoptosis and therapy
1999
The Causes and Consequences of Polyploidy in Normal Development and Cancer
2011
The role of the bcl-2/ced-9 gene family in cancer and general implications of defects in cell death control for tumourigenesis and resistance to chemotherapy
1997
Local and distant recurrences in rectal cancer patients are predicted by the nonspecific immune response; specific immune response has only a systemic effect - a histopathological and immunohistochemical study
2001
MIB-1 labelling index is an independent prognostic marker in primary breast cancer
1998
Loss of IFN-γ Pathway Genes in Tumor Cells as a Mechanism of Resistance to Anti-CTLA-4 Therapy
2016 StandoutNobel
Prognostic value of intratumoral CD8+ T lymphocyte in extrahepatic bile duct carcinoma as essential immune response
2003
Aberrant Expression of Cyclin D1 Is Associated with Poor Prognosis in Early Stage Cervical Cancer of the Uterus
2001
Immune system and prognosis in colorectal cancer: a detailed immunohistochemical analysis
2004
Inhibition of Prostate Tumor Cell Hyaluronan Synthesis Impairs Subcutaneous Growth and Vascularization in Immunocompromised Mice
2002
Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer
2016 Standout
Cancer immunology—analysis of host and tumor factors for personalized medicine
2011
Prognostic value of tumor infiltrating lymphocytes in the vertical growth phase of primary cutaneous melanoma
1996
Interferon γ inhibits growth of human pancreatic carcinoma cells via caspase-1 dependent induction of apoptosis
2001
Proliferative activity of intratumoral CD8(+) T-lymphocytes as a prognostic factor in human renal cell carcinoma: clinicopathologic demonstration of antitumor immunity.
2001
Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical Outcome
2006 StandoutScience
The Bcl-2 Protein Family: Arbiters of Cell Survival
1998 StandoutScience
SPAS-1 (stimulator of prostatic adenocarcinoma-specific T cells)/SH3GLB2: A prostate tumor antigen identified by CTLA-4 blockade
2008 StandoutNobel
Cyclin D1 expression in invasive breast cancer. Correlations and prognostic value.
1997
Integrated NY-ESO-1 antibody and CD8+T-cell responses correlate with clinical benefit in advanced melanoma patients treated with ipilimumab
2011 StandoutNobel
In Situ Cytotoxic and Memory T Cells Predict Outcome in Patients With Early-Stage Colorectal Cancer
2009
Cellular Proliferative Fraction of Metastatic Lymph Nodes Predicts Survival in Stage D1 (TxN+MO) Prostate Cancer
1996
Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and Promotion
2011 StandoutScience
Mussel-Inspired Surface Chemistry for Multifunctional Coatings
2007 StandoutScience
Tumor cell senescence in cancer treatment.
2003
Cell intrinsic mechanisms of T‐cell inhibition and application to cancer therapy
2008 StandoutNobel
Retinoblastoma protein family in cell cycle and cancer: A review
1996
Immunologic and clinical effects of antibody blockade of cytotoxic T lymphocyte-associated antigen 4 in previously vaccinated cancer patients
2008 StandoutNobel
Biologic activity of cytotoxic T lymphocyte-associated antigen 4 antibody blockade in previously vaccinated metastatic melanoma and ovarian carcinoma patients
2003 StandoutNobel
Evaluation of the prognostic potential of hyaluronic acid and hyaluronidase (HYAL1) for prostate cancer.
2003
The Role of Hyaluronic Acid in Hemopoietic Stem Cell Biology
2006
Cell Proliferation Assessed by Ki-67 Immunoreactivity on Formalin Fixed Tissues is a Predictive Factor for Survival in Prostate Cancer
1997
B7-H3 and B7x are highly expressed in human prostate cancer and associated with disease spread and poor outcome
2007 StandoutNobel
CD8+ T cells infiltrated within cancer cell nests as a prognostic factor in human colorectal cancer.
1998
CD4+ and CD8+ T cells cooperate to improve prognosis of patients with esophageal squamous cell carcinoma.
2003
HUMAN T CELL RESPONSES AGAINST MELANOMA
2005
Tumor-Associated Lymphocytes As an Independent Predictor of Response to Neoadjuvant Chemotherapy in Breast Cancer
2009
Anti-CCR4 mAb selectively depletes effector-type FoxP3+CD4+regulatory T cells, evoking antitumor immune responses in humans
2013 StandoutNobel
T cell exclusion, immune privilege, and the tumor microenvironment
2015 StandoutScience
PD-1 and CTLA-4 combination blockade expands infiltrating T cells and reduces regulatory T and myeloid cells within B16 melanoma tumors
2010 StandoutNobel
CTLA-4 blockade enhances polyfunctional NY-ESO-1 specific T cell responses in metastatic melanoma patients with clinical benefit
2008 StandoutNobel
The prognostic value of oncogenic antigen 519 (OA‐519) expression and proliferative activity detected by antibody MIB‐I in node‐negative breast cancer
1995
ELEVATED TISSUE EXPRESSION OF HYALURONIC ACID AND HYALURONIDASE VALIDATES THE HA-HAase URINE TEST FOR BLADDER CANCER
2001
Tumor cell-associated hyaluronan as an unfavorable prognostic factor in colorectal cancer.
1998
Intratumoral T-Cell Infiltrates and MHC Class I Expression in Patients with Stage IV Melanoma
2005
Clinical Significance of Programmed Death-1 Ligand-1 and Programmed Death-1 Ligand-2 Expression in Human Esophageal Cancer
2005
Prognostic significance of tumor cell proliferation rate as determined by the MIB-1 antibody in breast carcinoma: its relationship with vimentin and p53 protein.
1996
Normal development is an integral part of tumorigenesis in T cell-specific PTEN-deficient mice
2008 StandoutNobel
Early onset of neoplasia in the prostate and skin of mice with tissue-specific deletion of Pten
2004 StandoutNobel
Prognostic significance of activated CD8(+) T cell infiltrations within esophageal carcinomas.
2001
Tumor-Infiltrating CD8+Lymphocytes Predict Clinical Outcome in Breast Cancer
2011
WAF1/p21 Protein Expression Is an Independent Prognostic Indicator in Superficial and Invasive Bladder Cancer
2000
Differential control of human Treg and effector T cells in tumor immunity by Fc-engineered anti–CTLA-4 antibody
2018 StandoutNobel
Microvessel Density as a Prognostic Factor in Women with Breast Cancer
2004
Works of P. Lipponen being referenced
Hyaluronan expression in gastric cancer cells is associated with local and nodal spread and reduced survival rate
1999
Prognostic Value of Ki-67Expression in Renal CellCarcinomas
1997
Proliferating cell nuclear antigen and p53 expression as prognostic factors in T1‐2MO prostatic adenocarcinoma
1994
Prognostic value and expression of p21(waf1/cip1) protein in prostate cancer
1999
Apoptosis suppressing protein bcl‐2 is expressed in well‐differentiated breast carcinomas with favourable prognosis
1995
Prognostic factors in axillary lymph node-negative (pN−) breast carcinomas
1991
Expression of tumour-suppressor gene Rb, apoptosis-suppressing protein Bcl-2 and c-Myc have no independent prognostic value in renal adenocarcinoma
1995
Apoptosis in breast cancer as related to histopathological characteristics and prognosis
1994
Expression of retinoblastoma gene protein (Rb) in breast cancer as related to established prognostic factors and survival
1995
Lymphocyte infiltrates as a prognostic variable in female breast cancer
1992
Expression of p21(waf1/cip1) Protein in Transitional Cell Bladder Tumours and Its Prognostic Value
1998
Prognostic value of tumour-infiltrating lymphocytes (TILs) in colorectal cancer
1997
Tumour vascularity and basement membrane structure in breast cancer as related to tumour histology and prognosis
1994
Hormone Receptors as Prognostic Factors in Female: Breast Cancer
1991
Tumour infiltrating lymphocytes as an independent prognostic factor in transitional cell bladder cancer
1993
Histological grade, perineural infiltration, tumour-infiltrating lymphocytes and apoptosis as determinants of long-term prognosis in prostatic adenocarcinoma
1994
High stromal hyaluronan level is associated with poor differentiation and metastasis in prostate cancer
2001
Mitotic activity and prognosis in prostatic adenocarcinoma
1995
p53 protein expression in breast cancer as related to histopathological characteristics and prognosis
1993
The important prognostic value of Ki-67 expression as determined by image analysis in breast cancer
1996
Clinical contribution of bcl-2, p53 and Ki-67 proteins in pancreatic ductal adenocarcinoma.
1998
Expression of cyclin A and D proteins in prostate cancer and their relation to clinopathological variables and patient survival
1999
Value of Ki-67 Immunolabelling as a Prognostic Factor in Prostate Cancer
1997
Tumour-infiltrating lymphocytes: A prognostic factor of PSA-free survival in patients with local prostate carcinoma treated by radical prostatectomy.
2006